67.18
price down icon0.22%   -0.15
after-market  After Hours:  67.24  0.06   +0.09%
loading
CVS Health Corp stock is currently priced at $67.18, with a 24-hour trading volume of 6.32M. It has seen a -0.22% decreased in the last 24 hours and a -15.31% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $67.32 pivot point. If it approaches the $66.89 support level, significant changes may occur.
Previous Close:
$67.33
Open:
$67.21
24h Volume:
6.32M
Market Cap:
$84.68B
Revenue:
$357.78B
Net Income/Loss:
$8.34B
P/E Ratio:
10.13
EPS:
6.63
Net Cash Flow:
$10.40B
1W Performance:
-3.68%
1M Performance:
-15.31%
6M Performance:
-1.18%
1Y Performance:
-7.03%
1D Range:
Value
$66.75
$67.42
52W Range:
Value
$64.41
$83.25

CVS Health Corp Stock (CVS) Company Profile

Name
Name
CVS Health Corp
Name
Phone
401-765-1500
Name
Address
One CVS Drive, Woonsocket
Name
Employee
160,000
Name
Twitter
@cvshealth
Name
Next Earnings Date
2024-05-16
Name
Latest SEC Filings
Name
CVS's Discussions on Twitter

CVS Health Corp Stock (CVS) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-06-24 Initiated Barclays Equal Weight
Feb-26-24 Initiated Leerink Partners Outperform
Dec-22-23 Initiated HSBC Securities Buy
Sep-19-23 Upgrade Evercore ISI In-line → Outperform
Sep-12-23 Upgrade Wolfe Research Peer Perform → Outperform
Aug-18-23 Downgrade Edward Jones Buy → Hold
May-26-23 Initiated Piper Sandler Overweight
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Jan-03-23 Downgrade Evercore ISI Outperform → In-line
Nov-23-22 Resumed Morgan Stanley Overweight
Jun-17-22 Initiated Loop Capital Buy
May-27-22 Downgrade Bernstein Outperform → Mkt Perform
Mar-29-22 Downgrade Deutsche Bank Buy → Hold
Feb-11-22 Downgrade Raymond James Strong Buy → Outperform
Dec-14-21 Initiated Goldman Buy
Dec-01-21 Initiated Seaport Research Partners Buy
May-19-21 Initiated Wells Fargo Equal Weight
Mar-17-21 Downgrade Guggenheim Buy → Neutral
Jan-08-21 Upgrade Jefferies Hold → Buy
Sep-17-20 Initiated Piper Sandler Overweight
Jul-01-20 Initiated SVB Leerink Mkt Perform
May-14-20 Upgrade Credit Suisse Neutral → Outperform
Sep-27-19 Resumed RBC Capital Mkts Outperform
Sep-12-19 Initiated Deutsche Bank Buy
Jun-05-19 Upgrade Standpoint Research Hold → Buy
Apr-29-19 Downgrade Credit Suisse Outperform → Neutral
Apr-18-19 Initiated Guggenheim Buy
Apr-15-19 Downgrade Oppenheimer Outperform → Perform
Apr-10-19 Reiterated BofA/Merrill Buy
Mar-13-19 Initiated Bernstein Outperform
Feb-20-19 Downgrade Wells Fargo Outperform → Market Perform
Jan-17-19 Initiated UBS Buy
Dec-18-18 Initiated Barclays Overweight
Nov-29-18 Resumed Goldman Neutral
Nov-28-18 Initiated Evercore ISI Outperform
Oct-26-18 Resumed Wolfe Research Peer Perform
Jul-09-18 Upgrade Citigroup Neutral → Buy
Feb-27-18 Resumed BofA/Merrill Buy
Feb-13-18 Reiterated Citigroup Neutral
View All

CVS Health Corp Stock (CVS) Financials Data

CVS Health Corp (CVS) Revenue 2024

CVS reported a revenue (TTM) of $357.78 billion for the quarter ending December 31, 2023, a +10.95% rise year-over-year.
loading

CVS Health Corp (CVS) Net Income 2024

CVS net income (TTM) was $8.34 billion for the quarter ending December 31, 2023, a +93.55% increase year-over-year.
loading

CVS Health Corp (CVS) Cash Flow 2024

CVS recorded a free cash flow (TTM) of $10.39 billion for the quarter ending December 31, 2023, a -22.71% decrease year-over-year.
loading

CVS Health Corp (CVS) Earnings per Share 2024

CVS earnings per share (TTM) was $6.46 for the quarter ending December 31, 2023, a +100.62% growth year-over-year.
loading

CVS Health Corp Stock (CVS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Shah Prem S
EVP and Pres-Pharm, Consumer W
Feb 16 '24
Sale
76.95
29,473
2,267,947
39,765
LUDWIG EDWARD J
Director
Nov 03 '23
Buy
70.47
2,000
140,930
20,630
Clark James David
SVP, Cont & Chief Acct Officer
Aug 03 '23
Sale
74.92
25,759
1,930,004
4,698
Lynch Karen S
President and CEO
May 03 '23
Buy
69.75
14,000
976,567
431,392
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
healthcare_plans CI
$354.47
price down icon 0.01%
healthcare_plans ELV
$537.26
price down icon 0.45%
healthcare_plans CNC
$74.00
price down icon 2.22%
healthcare_plans HUM
$305.90
price down icon 1.77%
healthcare_plans MOH
$342.23
price down icon 2.86%
Cap:     |  Volume (24h):